This company is a Boston-based biopharmaceutical company developing immune-based approaches.
Boston Immune Technologies & Therapeutics has raised $4.0M in total funding. The most recent round was Grant. The last funding was announced in August 2024.
Boston Immune Technologies & Therapeutics's investors include Hatteras Venture Partners, BeiGene, National Institutes of Health, National Institute of Health.
Boston Immune Technologies & Therapeutics is headquartered in Winchester, United States.
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
Boston Immune Technologies & Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Boston Immune Technologies & Therapeutics — Funding & Investors." VCBacked, August 16, 2024, https://www.vcbacked.co/company/boston-immune-technologies-therapeutics. Accessed July 20, 2026.
VCBacked. (2024). Boston Immune Technologies & Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/boston-immune-technologies-therapeutics
{{cite web |title=Boston Immune Technologies & Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/boston-immune-technologies-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated